4 thoughts on antibiotic resistance from expert Dr. Barbara Murray

Antibiotic resistance took the national spotlight in May when scientists confirmed the discovery of a strain of E. coli resistant to colistin, the antibiotic of last resort, for the first time in the U.S. In an interview published in JAMA, Barbara Murray, MD, director of the division of infectious diseases at the University of Texas Health Science Center at Houston and an antibiotic resistance expert, talked about the challenges posed by antibiotic-resistant bugs.

Advertisement

Here are four thoughts from Ms. Murray, pulled from the interview.

1. Resistance to colistin. “Colistin has become the last go-to antibiotic for some of our multidrug-resistant bacteria … When you’re left with only one drug and now you see resistance developing in it, it’s very concerning.”

2. Communicating with patients on antibiotic prescriptions. “The big pressure in an outpatient setting is for respiratory infections — colds, sore throats and sinusitis — and the vast majority of those are viral. I think we just have to tell patients that this is a virus. And it’s not good for you or the world to put you on antibiotics for a viral infection against which antibiotics don’t work.”

3. The failure of antibiotic stewardship programs. “When you’re dealing with a very sick patient in the hospital, you’re not thinking of the public health implications, you’re just thinking of that patient. As clinicians, we tend to just keep changing antibiotics and adding new antibiotics. And I can’t say that’s wrong. But at the same time, it does drive the selective pressure for resistance.” 

4. The quick spread of resistance. “It’s very difficult to keep things from spreading in the hospital, and that’s where the real danger is. In the hospital setting, the bacteria that may acquire the mcr-1 gene [that makes bacteria resistant to colistin] may already be resistant to everything else.”

More articles on antibiotic resistance:
CDC to provide $67 million to health departments for fight against antibiotic resistance
HHS forms international partnership to develop new antibiotics: 10 things to know
Antibiotic-resistant bacteria found in Florida wastewater following sewage spill

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

  • How many of you have felt like a flea in a jar? If you put fleas in a jar, they…

Advertisement

Comments are closed.